{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-081888","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2024-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.735429+00:00","generated_at":"2026-05-31T18:05:01.910611+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Entero Therapeutics CSO Jack Syage resigns; salary cut to $66,560 as cost reduction","bullets":["Dr. Jack Syage resigned as Chief Scientific Officer effective July 17, 2024, will remain President and Board member.","Resignation is part of cost reduction measures, not due to any disagreement with company policies.","Annual base salary reduced to $66,560, effective July 1, 2024; other compensation terms unchanged.","CEO James Sapirstein signed the filing on July 23, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-081888","json":"https://secwatch.observer/filing/0001104659-24-081888.json","markdown":"https://secwatch.observer/filing/0001104659-24-081888.md","text":"https://secwatch.observer/filing/0001104659-24-081888.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924081888/0001104659-24-081888-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924081888/tm2419937d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T18:05:01.910611+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"99e321776f","claim":"Jack Syage resigned as Chief Scientific Officer at GridAI Technologies Corp..","evidence_excerpt":"Dr. Jack Syage, the Company’s Chief Scientific Officer, President and member of the Board, whereby he tendered his resignation from the role of Chief Scientific Officer of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924081888/0001104659-24-081888-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Scientific Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}